DexCom (DXCM) PT Raised to $157 at Piper Jaffray
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
DexCom (DXCM) PT Raised to $150 at Oppenheimer
November 7, 2018 9:35 AM ESTOppenheimer analyst Steven Lichtman raised the price target on DexCom (NASDAQ: DXCM) to $150.00 (from $125.00) while maintaining a Outperform rating.
The analyst commented, "DXCM's 3Q18 sales of $267M (+45% cc) beat our/consensus' $241/$243M, led by strong outperformance in International and better... More
DexCom (DXCM) PT Raised to $170 at Stephens
November 7, 2018 8:34 AM ESTStephens analyst Chris Cooley raised the price target on DexCom (NASDAQ: DXCM) to $170.00 (from $160.00) while maintaining a Overweight rating following the company's 3Q report. Sales were in-line with Stephens' well-above consensus revenue estimate.
DXCM appears well positioned to continue to deliver... More
